Time to individualize duration of parenteral anticoagulation in pulmonary thromboembolism?
[...]giving oral anticoagulant (OAC) from the first day may be somewhat counterproductive (at least theoretically) because of well-known prothrombotic action of warfarin in the first days of administration. Namely, heparin not only acts more rapidly than OAC, but it also has a better antithrombotic...
Gespeichert in:
Veröffentlicht in: | The American journal of emergency medicine 2012-07, Vol.30 (6), p.1004-1006 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]giving oral anticoagulant (OAC) from the first day may be somewhat counterproductive (at least theoretically) because of well-known prothrombotic action of warfarin in the first days of administration. Namely, heparin not only acts more rapidly than OAC, but it also has a better antithrombotic effect [12-14]. [...]low-molecular-weight heparin (LMWH) is preferred to unfractionated heparin (UFH) for the initial treatment of acute nonmassive PTE Antithrombotic Therapy for Venous Thromboembolic Disease- American College of Chest Physicians Guidelines (8th Edition) recommendation grade 1A) [15]. |
---|---|
ISSN: | 0735-6757 1532-8171 |
DOI: | 10.1016/j.ajem.2012.03.016 |